IgA Nephropathy (Berger Disease)

Overview


Plain-Language Overview

IgA Nephropathy (Berger Disease) is a condition that affects the kidneys, which are vital organs responsible for filtering waste from the blood. It occurs when a protein called immunoglobulin A (IgA) builds up in the kidney's filtering units, causing inflammation. This inflammation can lead to blood and protein leaking into the urine, which may be noticed as dark or bloody urine. Over time, the damage can reduce kidney function, potentially leading to chronic kidney disease. The disease often starts in childhood or early adulthood and can vary widely in severity among individuals.

Clinical Definition

IgA Nephropathy (Berger Disease) is a primary glomerulonephritis characterized by the deposition of IgA immune complexes in the mesangium of the glomeruli. The pathogenesis involves abnormal glycosylation of IgA1 molecules, leading to immune complex formation and mesangial proliferation. This results in glomerular inflammation and injury, manifesting clinically as hematuria and sometimes proteinuria. It is the most common cause of primary glomerulonephritis worldwide and can progress to end-stage renal disease in a subset of patients. The disease is often preceded by an upper respiratory tract infection, reflecting mucosal immune system involvement. Diagnosis and prognosis depend on clinical presentation and histopathologic findings.

Inciting Event

Locked content

Latency Period

Locked content

Diagnostic Delay

Locked content

Clinical Presentation


Signs & Symptoms

Locked content

History of Present Illness

Locked content

Past Medical History

Locked content

Family History

Locked content

Physical Exam Findings

Locked content

Diagnostic Workup


Diagnostic Criteria

Locked content

Pathophysiology


Key Mechanisms

Locked content

Organs

Locked content

Tissues

Locked content

Cells

Locked content

Chemical Mediators

Locked content

Treatments


Pharmacological Treatments

Locked content

Non-pharmacological Treatments

Locked content

Prevention


Pharmacological Prevention

Locked content

Non-pharmacological Prevention

Locked content

Outcome & Complications


Complications

Locked content

Short-term Sequelae

Locked content

Long-term Sequelae

Locked content

Differential Diagnoses


Differentials

Locked content

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.